Role of cetrorelix in the prevention and treatment of ovarian hyperstimulation syndrome: a prospective case control study.
VV Mishra, PH Rane, RS Aggarwal… - International Journal of …, 2023 - go.gale.com
Background: Ovarian hyperstimulation syndrome (OHSS) has intrigued clinicians for many
years because of its devastating consequences. As an iatrogenic condition resulting from …
years because of its devastating consequences. As an iatrogenic condition resulting from …
GnRH antagonist Cetrorelix administration before hCG for protection of ovarian Hyperstimulation syndrome
SA Hebisha, BA Aboelazm, HN Sallam - The Journal of Obstetrics and …, 2017 - Springer
Objective Studying the effect of GnRH antagonist administration on the day of hCG to cases
of IVF/ICSI with estradiol level above 5000 ng/dl for protection of ovarian hyperstimulation …
of IVF/ICSI with estradiol level above 5000 ng/dl for protection of ovarian hyperstimulation …
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian …
M Ludwig, RE Felberbaum, P Devroey… - Archives of Gynecology …, 2000 - Springer
A prospective, randomized study was performed to compare the efficiency of hormonal
stimulation for IVF (in vitro fertilization) in either the long luteal protocol, using the LHRH …
stimulation for IVF (in vitro fertilization) in either the long luteal protocol, using the LHRH …
The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study
C Zeng, J Shang, AM Jin, PL Wu, X Li… - Archives of Gynecology …, 2019 - Springer
Purpose Ovarian hyperstimulation syndrome (OHSS) is a serious complication of assisted
reproductive technology (ART) treatment. However, there are limited data regarding the …
reproductive technology (ART) treatment. However, there are limited data regarding the …
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
G Ragni, W Vegetti, A Riccaboni, B Engl… - Human …, 2005 - academic.oup.com
Abstract BACKGROUND: During IVF or ICSI cycles, ovarian hyperstimulation syndrome
(OHSS) is a major problem. The aim of this prospective, multicentre, comparative study …
(OHSS) is a major problem. The aim of this prospective, multicentre, comparative study …
[HTML][HTML] Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
BK Rabati, SN Zeidi - Journal of Research in Medical Sciences …, 2012 - ncbi.nlm.nih.gov
Background: Given the controversies regarding the effectiveness of gonadotropin-releasing
hormone (GnRH) antagonists in prevention of ovarian hyper stimulation syndrome …
hormone (GnRH) antagonists in prevention of ovarian hyper stimulation syndrome …
Treatment of ovarian hyperstimulation syndrome using gonadotropin releasing hormone antagonist: a pilot study
MA Hosseini, A Mahdavi, A Aleyasin… - Gynecological …, 2012 - Taylor & Francis
Objective: This novel study describes an effective outpatient treatment for ovarian
hyperstimulation syndrome (OHSS) that results in rapid normalization of symptoms. Study …
hyperstimulation syndrome (OHSS) that results in rapid normalization of symptoms. Study …
Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients at high risk of ovarian hyperstimulation syndrome: a prospective randomized …
S Ferrero, LH Abbamonte, MR Privamera, S Levi… - Fertility and …, 2010 - fertstert.org
OBJECTIVE: To compare the flexible GnRH antagonist and the GnRH agonist long protocol
in patients at high risk of OHSS undergoing IVF. DESIGN: Single-centre open label …
in patients at high risk of OHSS undergoing IVF. DESIGN: Single-centre open label …
[PDF][PDF] Prevention and treatment of OHSS by administration of GnRH antagonist in the early luteal phase of controlled ovarian hyperstimulationcycles
C Chen, L Liu, Y Geng, C Yang, T Li, Y Gao - Int J Clin Exp Pathol, 2017 - e-century.us
To investigate the treatment effect of gonadotropin releasing hormone (GnRH) antagonist in
the early luteal phase on ovarian hyperstimulation syndrome (OHSS) for in vitro fertilization …
the early luteal phase on ovarian hyperstimulation syndrome (OHSS) for in vitro fertilization …
Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone …
L Fang, M Ruan, S Yang, X Qu, H Chen, J Zhao… - Ann Palliat …, 2021 - opus.lib.uts.edu.au
BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a severe disease that can
lead to serious complication. Letrozole has been applied during controlled ovarian …
lead to serious complication. Letrozole has been applied during controlled ovarian …